These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4051513)

  • 1. [Tissue concentration of 4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor].
    Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Shomura T; Kawamura K
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1975-9. PubMed ID: 4051513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tissue concentration of (2"R)-4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor (second report)].
    Masuda H; Hirose J; Ohtawara Y; Suzuki K; Tajima A; Aso Y; Hiramatsu K; Shomura T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2912-6. PubMed ID: 3662546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II collaborative study of (2''R)-4'-0-tetrahydropyranyladriamycin (THP) for urological malignancies--Urological Co-operative THP Study Group].
    Niijima T; Koyanagi T; Sakashita S; Origasa S; Akaza H; Machida T; Koiso K; Rinsho K; Aso Y; Suzuki K
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):224-31. PubMed ID: 3947104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravesical chemotherapy of (2''R)-4'-O-tetrahydropyranyladriamycin in bladder tumor].
    Masuda H; Hirose J; Suzuki K; Tajima A; Aso Y
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2411-4. PubMed ID: 3729494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Appropriate intravesical retention time of pirarubicin concentration based on its level in tumor tissue, anti-tumor effect and side effect in intravesical instillation therapy for bladder tumor].
    Kobayashi M; Sugaya Y; Yuzawa M; Ochi M; Morita T; Kobayashi Y; Tokue A; Hara Y
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1771-4. PubMed ID: 9757205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN; Riggi M; Rougier P; Chabot GG; Ramirez LH; Zhao Z; Bognel C; Ardouin P; Herait P; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1550-4. PubMed ID: 8453622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue levels of pirarubicin (THP) in dogs following intra-arterial infusion].
    Sumiyoshi Y; Yokota K; Akiyama M; Kawaoto H; Kosugi I
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1621-6. PubMed ID: 1872619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of TFAR19(PDCD5) in normal human kidney, renal clear cell carcinoma, normal human bladder and bladder carcinoma].
    Xiong L; Tan WL; Yu ZC; Wu YD; Huang H; Zhao GZ; Zhu WH; Zheng SB
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):805-9. PubMed ID: 16793605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A; Yamashita K
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infiltration and tissue concentration of intravesically instilled (2"R)-4'-O-tetrahydropyranyladriamycin or adriamycin in rat bladder tumor induced by BBN].
    Masuda H; Hirai M; Ohtawara Y; Tajima A; Aso Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Apr; 81(4):577-82. PubMed ID: 2374330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of retention time of intravesical instillation therapy with pirarubicin (THP)].
    Sugano O; Shoji N; Hatakeyama T; Kato H
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1169-74. PubMed ID: 8751805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
    Nakajima O; Imamura Y; Matsumoto A; Koyama Y; Shomura T; Kawamura K; Murata S
    Gan To Kagaku Ryoho; 1986 Feb; 13(2):261-70. PubMed ID: 3947106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH; Bai JL; Zhang SS; Ma PC; Wan JH
    Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized study of single early instillation of (2"R)-4'-O-tetrahydropyranyl-doxorubicin for a single superficial bladder carcinoma.
    Okamura K; Ono Y; Kinukawa T; Matsuura O; Yamada S; Ando T; Fukatsu T; Ohno Y; Ohshima S;
    Cancer; 2002 May; 94(9):2363-8. PubMed ID: 12015761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of death receptor 4 mediated apoptosis and cytotoxicity in renal cell carcinoma cells by subtoxic concentrations of doxorubicin.
    Jin X; Wu XX; Abdel-Muneem Nouh MA; Kakehi Y
    J Urol; 2007 May; 177(5):1894-9. PubMed ID: 17437844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
    Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
    Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of intracellular concentration and duration of contamination of pirarubicin and adriamycin in human bladder cancer cell lines and human bladder normal mucosa cell line].
    Saika T; Tsushima T; Nasu Y; Akebi N; Ohmori H
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):905-9. PubMed ID: 8678540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.